About this trial
Psychiatric disorders often require specific treatments, usually involving medications called psychotropic drugs. While effective, these medications can cause significant side effects. One of the most common is hypersalivation (excess saliva), which can make swallowing difficult and be very uncomfortable in daily life.
Current medication-based solutions are often not very effective and may cause additional side effects. For this reason, we are exploring a different approach: using chewing gum as a form of rehabilitation.
The goal of this study is to determine whether chewing gum can help reduce excessive saliva. To do this, we will compare two groups: one that will follow a swallowing rehabilitation program including chewing gum, and another that will not.
We hope this simple, non-drug-based approach will improve the management of hypersalivation. More broadly, this research aims to highlight innovative and accessible solutions in psychiatry, showing that alternative strategies-sometimes very simple ones-can also be effective.
Eligibility criteria
Qualifiers
Adults aged 18 to 65 years.
Hospitalized at Cadillac Hospital, either in full inpatient care or at the rehabilitation facility, excluding the UHSA.
Experiencing iatrogenic hypersalivation induced by psychotropic medications.
Salivary flow causing functional impairment for the patient, or observed by family members or healthcare providers.
Disqualifiers
Anatomical/morphological anomaly affecting mastication/swallowing
Swallowing disorder of organic etiology (e.g., neurological deficit due to stroke, neurodegenerative disease, oropharyngeal surgery, etc.)
Known risk of aspiration with liquids
Patient refusal of chewing gum or inability to obtain consent (e.g., non-communicative patients)
Trial design
Treatments tested in this trial
- chewing gum mastication